Skip to main content
. Author manuscript; available in PMC: 2017 Jul 10.
Published in final edited form as: Stat Med. 2016 Feb 1;35(15):2516–2524. doi: 10.1002/sim.6886

Table 3.

Proportion of trials each dose was recommended. All designs except the CRM were simulated with addition of the safety rule. The CRM with the safety rule is denoted by the CRM+S. The target DLT probability is 0.20 and the total sample size is n = 30. Numbers at the true MTD are in bold.

d1 d2 d3 d4 d5 d6
Scenario 1 0.05 0.10 0.20 0.30 0.50 0.70
mTPI 0.05 0.26 0.41 0.24 0.03 0.00
RED 0.05 0.20 0.39 0.33 0.04 0.00
t-statistics 0.05 0.26 0.44 0.22 0.02 0.00
CRM+S 0.05 0.28 0.46 0.20 0.00 0.00
CRM 0.01 0.19 0.52 0.28 0.01 0.00
Scenario 2 0.01 0.05 0.50 0.60 0.70 0.80
mTPI 0.01 0.93 0.06 0.00 0.00 0.00
RED 0.01 0.94 0.05 0.00 0.00 0.00
t-statistics 0.01 0.93 0.06 0.00 0.00 0.00
CRM+S 0.01 0.87 0.10 0.02 0.00 0.00
CRM 0.00 0.66 0.34 0.00 0.00 0.00
Scenario 3 0.05 0.06 0.08 0.11 0.19 0.34
mTPI 0.02 0.05 0.10 0.22 0.42 0.19
RED 0.02 0.02 0.05 0.19 0.44 0.27
t-statistics 0.02 0.05 0.13 0.28 0.37 0.14
CRM+S 0.01 0.04 0.12 0.33 0.46 0.04
CRM 0.00 0.01 0.06 0.31 0.56 0.05
Scenario 4 0.06 0.08 0.12 0.18 0.40 0.71
mTPI 0.04 0.10 0.22 0.46 0.15 0.00
RED 0.03 0.06 0.16 0.55 0.19 0.00
t-statistics 0.05 0.11 0.27 0.47 0.11 0.00
CRM+S 0.02 0.10 0.28 0.54 0.06 0.00
CRM 0.00 0.04 0.21 0.64 0.10 0.00
Scenario 5 0.00 0.00 0.03 0.05 0.11 0.22
mTPI 0.00 0.00 0.01 0.06 0.32 0.60
RED 0.00 0.00 0.01 0.04 0.28 0.66
t-statistics 0.00 0.00 0.01 0.09 0.37 0.53
CRM+S 0.00 0.00 0.02 0.14 0.58 0.27
CRM 0.00 0.00 0.00 0.05 0.63 0.32